{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T02:50:33Z","timestamp":1749783033673},"reference-count":67,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,26]]},"DOI":"10.7759\/cureus.47720","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T13:04:49Z","timestamp":1698325489000},"source":"Crossref","is-referenced-by-count":2,"title":["Topical Iron Chelator Therapy: Current Status and Future Prospects"],"prefix":"10.7759","author":[{"given":"Tanya","family":"Ramadoss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek S","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey N","family":"Mayrovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/nu9070671","article-title":"Antioxidants mediate both iron homeostasis and oxidative stress","volume":"9","author":"Imam MU","year":"2017","unstructured":"Imam MU, Zhang S, Ma J, Wang H, Wang F. Antioxidants mediate both iron homeostasis and oxidative stress. Nutrients. 2017, 9:671. 10.3390\/nu9070671","journal-title":"Nutrients"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2004.06.021","article-title":"Iron metabolism and toxicity","volume":"202","author":"Papanikolaou G","year":"2005","unstructured":"Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005, 202:199-211. 10.1016\/j.taap.2004.06.021","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0120-5","article-title":"Body iron metabolism and pathophysiology of iron overload","volume":"88","author":"Kohgo Y","year":"2008","unstructured":"Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008, 88:7-15. 10.1007\/s12185-008-0120-5","journal-title":"Int J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1507104","article-title":"Iron-deficiency anemia","volume":"373","author":"Sakemi H","year":"2015","unstructured":"Sakemi H. Iron-deficiency anemia. N Engl J Med. 2015, 373:484-5. 10.1056\/NEJMc1507104","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195594","article-title":"Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia","volume":"113","author":"Silvestri L","year":"2009","unstructured":"Silvestri L, Guillem F, Pagani A, et al.. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. Blood. 2009, 113:5605-8. 10.1182\/blood-2008-12-195594","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/2042098613482484","article-title":"Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications","volume":"4","author":"Heidelbaugh JJ","year":"2013","unstructured":"Heidelbaugh JJ. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications. Ther Adv Drug Saf. 2013, 4:125-33. 10.1177\/2042098613482484","journal-title":"Ther Adv Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko M","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007, 39:44-84. 10.1016\/j.biocel.2006.07.001","journal-title":"Int J Biochem Cell Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-155952","article-title":"Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator","volume":"113","author":"Jiao Y","year":"2009","unstructured":"Jiao Y, Wilkinson J 4th, Di X, et al.. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood. 2009, 113:462-9. 10.1182\/blood-2008-05-155952","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S79458","article-title":"Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes","volume":"10","author":"Kontoghiorghe CN","year":"2016","unstructured":"Kontoghiorghe CN, Kontoghiorghes GJ. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes. Drug Des Devel Ther. 2016, 10:465-81. 10.2147\/DDDT.S79458","journal-title":"Drug Des Devel Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4911205","article-title":"Iron chelators in treatment of iron overload","volume":"2022","author":"Entezari S","year":"2022","unstructured":"Entezari S, Haghi SM, Norouzkhani N, et al.. Iron chelators in treatment of iron overload. J Toxicol. 2022, 2022:4911205. 10.1155\/2022\/4911205","journal-title":"J Toxicol"},{"key":"ref11","article-title":"A review on iron chelators in treatment of iron overload syndromes","volume":"10","author":"Mobarra N","year":"2016","unstructured":"Mobarra N, Shanaki M, Ehteram H, et al.. A review on iron chelators in treatment of iron overload syndromes. Int J Hematol Oncol Stem Cell Res. 2016, 10:239-47.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1867","article-title":"Role of deferiprone in chelation therapy for transfusional iron overload","volume":"102","author":"Hoffbrand AV","year":"2003","unstructured":"Hoffbrand AV, Cohen A, Hershko C. Role of deferiprone in chelation therapy for transfusional iron overload. Blood. 2003, 102:17-24. 10.1182\/blood-2002-06-1867","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212502","article-title":"Advances in iron chelation therapy: transitioning to a new oral formulation","volume":"6","author":"Shah NR","year":"2017","unstructured":"Shah NR. Advances in iron chelation therapy: transitioning to a new oral formulation. Drugs Context. 2017, 6:212502. 10.7573\/dic.212502","journal-title":"Drugs Context"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12613740","article-title":"Skin inflammation: reactive oxygen species and the role of iron","volume":"99","author":"Trenam CW","year":"1992","unstructured":"Trenam CW, Blake DR, Morris CJ. Skin inflammation: reactive oxygen species and the role of iron. J Invest Dermatol. 1992, 99:675-82. 10.1111\/1523-1747.ep12613740","journal-title":"J Invest Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13854","article-title":"Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome","volume":"28","author":"Burns EM","year":"2019","unstructured":"Burns EM, Ahmed H, Isedeh PN, et al.. Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome. Exp Dermatol. 2019, 28:136-41. 10.1111\/exd.13854","journal-title":"Exp Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1039\/b703861e","article-title":"Topical applications of iron chelators in photosensitization","volume":"6","author":"Juzeniene A","year":"2007","unstructured":"Juzeniene A, Juzenas P, Iani V, Moan J. Topical applications of iron chelators in photosensitization. Photochem Photobiol Sci. 2007, 6:1268-74. 10.1039\/b703861e","journal-title":"Photochem Photobiol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(00)00873-6","article-title":"Prevention of the photodamage in the hairless mouse dorsal skin by kojic acid as an iron chelator","volume":"411","author":"Mitani H","year":"2001","unstructured":"Mitani H, Koshiishi I, Sumita T, Imanari T. Prevention of the photodamage in the hairless mouse dorsal skin by kojic acid as an iron chelator. Eur J Pharmacol. 2001, 411:169-74. 10.1016\/s0014-2999(00)00873-6","journal-title":"Eur J Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(94)70218-7","article-title":"Evaluation of a topical iron chelator in animals and in human beings: short-term photoprotection by 2-furildioxime","volume":"31","author":"Bissett DL","year":"1994","unstructured":"Bissett DL, Oelrich DM, Hannon DP. Evaluation of a topical iron chelator in animals and in human beings: short-term photoprotection by 2-furildioxime. J Am Acad Dermatol. 1994, 31:572-8. 10.1016\/s0190-9622(94)70218-7","journal-title":"J Am Acad Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2005.02.015","article-title":"The sunburn cell: regulation of death and survival of the keratinocyte","volume":"37","author":"Van Laethem A","year":"2005","unstructured":"Van Laethem A, Claerhout S, Garmyn M, Agostinis P. The sunburn cell: regulation of death and survival of the keratinocyte. Int J Biochem Cell Biol. 2005, 37:1547-53. 10.1016\/j.biocel.2005.02.015","journal-title":"Int J Biochem Cell Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-013-1559-0","article-title":"Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites","volume":"46","author":"Hayes CS","year":"2014","unstructured":"Hayes CS, DeFeo-Mattox K, Woster PM, Gilmour SK. Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites. Amino Acids. 2014, 46:543-52. 10.1007\/s00726-013-1559-0","journal-title":"Amino Acids"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2010.14.2.91","article-title":"Pyrithione-zinc prevents UVB-induced epidermal hyperplasia by inducing HIF-1alpha","volume":"14","author":"Cho YS","year":"2010","unstructured":"Cho YS, Lee KH, Park JW. Pyrithione-zinc prevents UVB-induced epidermal hyperplasia by inducing HIF-1alpha. Korean J Physiol Pharmacol. 2010, 14:91-7. 10.4196\/kjpp.2010.14.2.91","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis M","year":"2014","unstructured":"Pasparakis M, Haase I, Nestle FO. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014, 14:289-301. 10.1038\/nri3646","journal-title":"Nat Rev Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/children9040537","article-title":"Children and ultraviolet radiation","volume":"9","author":"Gefeller O","year":"2022","unstructured":"Gefeller O, Diehl K. Children and ultraviolet radiation. Children (Basel). 2022, 9:10.3390\/children9040537","journal-title":"Children (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1991.tb02009.x","article-title":"Chronic ultraviolet radiation-induced increase in skin iron and the photoprotective effect of topically applied iron chelators","volume":"54","author":"Bissett DL","year":"1991","unstructured":"Bissett DL, Chatterjee R, Hannon DP. Chronic ultraviolet radiation-induced increase in skin iron and the photoprotective effect of topically applied iron chelators. Photochem Photobiol. 1991, 54:215-23. 10.1111\/j.1751-1097.1991.tb02009.x","journal-title":"Photochem Photobiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(96)90677-5","article-title":"Synergistic topical photoprotection by a combination of the iron chelator 2-furildioxime and sunscreen","volume":"35","author":"Bissett DL","year":"1996","unstructured":"Bissett DL, McBride JF. Synergistic topical photoprotection by a combination of the iron chelator 2-furildioxime and sunscreen. J Am Acad Dermatol. 1996, 35:546-9. 10.1016\/s0190-9622(96)90677-5","journal-title":"J Am Acad Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00156","article-title":"The role of iron in the skin and cutaneous wound healing","volume":"5","author":"Wright JA","year":"2014","unstructured":"Wright JA, Richards T, Srai SK. The role of iron in the skin and cutaneous wound healing. Front Pharmacol. 2014, 5:156. 10.3389\/fphar.2014.00156","journal-title":"Front Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-508","article-title":"Predictive factors of radiation-induced skin toxicity in breast cancer patients","volume":"10","author":"Chen MF","year":"2010","unstructured":"Chen MF, Chen WC, Lai CH, Hung CH, Liu KC, Cheng YH. Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer. 2010, 10:508. 10.1186\/1471-2407-10-508","journal-title":"BMC Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.09.062","article-title":"Induction of p53 and p21 proteins by gamma radiation in skin fibroblasts derived from breast cancer patients","volume":"58","author":"Torres M","year":"2004","unstructured":"Torres M, Al-Buhairi M, Alsbeih G. Induction of p53 and p21 proteins by gamma radiation in skin fibroblasts derived from breast cancer patients. Int J Radiat Oncol Biol Phys. 2004, 58:479-84. 10.1016\/j.ijrobp.2003.09.062","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2021.0021","article-title":"Deferoxamine to minimize fibrosis during radiation therapy","volume":"11","author":"Tevlin R","year":"2022","unstructured":"Tevlin R, Longaker MT, Wan DC. Deferoxamine to minimize fibrosis during radiation therapy. Adv Wound Care (New Rochelle). 2022, 11:548-59. 10.1089\/wound.2021.0021","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.10169","article-title":"Association between skin phototype and radiation dermatitis in patients with breast cancer treated with breast-conserving therapy: suntan reaction could be a good predictor for radiation pigmentation","volume":"52","author":"Yamazaki H","year":"2011","unstructured":"Yamazaki H, Yoshida K, Nishimura T, et al.. Association between skin phototype and radiation dermatitis in patients with breast cancer treated with breast-conserving therapy: suntan reaction could be a good predictor for radiation pigmentation. J Radiat Res. 2011, 52:496-501. 10.1269\/jrr.10169","journal-title":"J Radiat Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7785\/tcrtexpress.2013.600257","article-title":"Skin elasticity as a measure of radiation fibrosis: is it reproducible and does it correlate with patient and physician-reported measures?","volume":"13","author":"Nguyen NT","year":"2014","unstructured":"Nguyen NT, Roberge D, Freeman C, Wong C, Hines J, Turcotte RE. Skin elasticity as a measure of radiation fibrosis: is it reproducible and does it correlate with patient and physician-reported measures?. Technol Cancer Res Treat. 2014, 13:469-76. 10.7785\/tcrtexpress.2013.600257","journal-title":"Technol Cancer Res Treat"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0000000000002098","article-title":"Radiation-induced skin fibrosis: pathogenesis, current treatment options, and emerging therapeutics","volume":"83","author":"Borrelli MR","year":"2019","unstructured":"Borrelli MR, Shen AH, Lee GK, Momeni A, Longaker MT, Wan DC. Radiation-induced skin fibrosis: pathogenesis, current treatment options, and emerging therapeutics. Ann Plast Surg. 2019, 83:S59-64. 10.1097\/SAP.0000000000002098","journal-title":"Ann Plast Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0846.2003.00357.x","article-title":"Radiation-induced skin fibrosis after treatment of breast cancer: profilometric analysis","volume":"9","author":"Bourgeois JF","year":"2003","unstructured":"Bourgeois JF, Gourgou S, Kramar A, Lagarde JM, Gall Y, Guillot B. Radiation-induced skin fibrosis after treatment of breast cancer: profilometric analysis. Skin Res Technol. 2003, 9:39-42. 10.1034\/j.1600-0846.2003.00357.x","journal-title":"Skin Res Technol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.09.022","article-title":"Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy","volume":"91","author":"Pignol JP","year":"2015","unstructured":"Pignol JP, Vu TT, Mitera G, Bosnic S, Verkooijen HM, Truong P. Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 2015, 91:157-64. 10.1016\/j.ijrobp.2014.09.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.12788\/j.suponc.0009","article-title":"Characterization of skin reactions and pain reported by patients receiving radiation therapy for cancer at different sites","volume":"11","author":"Gewandter JS","year":"2013","unstructured":"Gewandter JS, Walker J, Heckler CE, Morrow GR, Ryan JL. Characterization of skin reactions and pain reported by patients receiving radiation therapy for cancer at different sites. J Support Oncol. 2013, 11:183-9. 10.12788\/j.suponc.0009","journal-title":"J Support Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16913","article-title":"A comparative analysis of deferoxamine treatment modalities for dermal radiation-induced fibrosis","volume":"25","author":"Lavin CV","year":"2021","unstructured":"Lavin CV, Abbas DB, Fahy EJ, et al.. A comparative analysis of deferoxamine treatment modalities for dermal radiation-induced fibrosis. J Cell Mol Med. 2021, 25:10028-38. 10.1111\/jcmm.16913","journal-title":"J Cell Mol Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69293-4","article-title":"Prophylactic treatment with transdermal deferoxamine mitigates radiation-induced skin fibrosis","volume":"10","author":"Shen AH","year":"2020","unstructured":"Shen AH, Borrelli MR, Adem S, et al.. Prophylactic treatment with transdermal deferoxamine mitigates radiation-induced skin fibrosis. Sci Rep. 2020, 10:12346. 10.1038\/s41598-020-69293-4","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14186","article-title":"Bax, Bak and beyond - mitochondrial performance in apoptosis","volume":"285","author":"Pe\u00f1a-Blanco A","year":"2018","unstructured":"Pe\u00f1a-Blanco A, Garc\u00eda-S\u00e1ez AJ. Bax, Bak and beyond - mitochondrial performance in apoptosis. FEBS J. 2018, 285:416-31. 10.1111\/febs.14186","journal-title":"FEBS J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051259","article-title":"The role of Caspase-2 in regulating cell fate","volume":"9","author":"Vigneswara V","year":"2020","unstructured":"Vigneswara V, Ahmed Z. The role of Caspase-2 in regulating cell fate. Cells. 2020, 9:10.3390\/cells9051259","journal-title":"Cells"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/nature12783","article-title":"Distinct fibroblast lineages determine dermal architecture in skin development and repair","volume":"504","author":"Driskell RR","year":"2013","unstructured":"Driskell RR, Lichtenberger BM, Hoste E, et al.. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature. 2013, 504:277-81. 10.1038\/nature12783","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.12.039","article-title":"Use of spectroscopic probes for detection of reactive oxygen species","volume":"368","author":"Bartosz G","year":"2006","unstructured":"Bartosz G. Use of spectroscopic probes for detection of reactive oxygen species. Clin Chim Acta. 2006, 368:53-76. 10.1016\/j.cca.2005.12.039","journal-title":"Clin Chim Acta"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2021.33.3.263","article-title":"Effects of particulate matter on healthy skin: a comparative study between high- and low-particulate matter periods","volume":"33","author":"Oh SJ","year":"2021","unstructured":"Oh SJ, Yoon D, Park JH, Lee JH. Effects of particulate matter on healthy skin: a comparative study between high- and low-particulate matter periods. Ann Dermatol. 2021, 33:263-70. 10.5021\/ad.2021.33.3.263","journal-title":"Ann Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121928","article-title":"Deferoxamine treatment improves antioxidant cosmeceutical formulation protection against cutaneous diesel engine exhaust exposure","volume":"10","author":"Pambianchi E","year":"2021","unstructured":"Pambianchi E, Ferrara F, Pecorelli A, Benedusi M, Choudhary H, Therrien JP, Valacchi G. Deferoxamine treatment improves antioxidant cosmeceutical formulation protection against cutaneous diesel engine exhaust exposure. Antioxidants (Basel). 2021, 10:10.3390\/antiox10121928","journal-title":"Antioxidants (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2786","article-title":"Need for improved definition of \u201cchronic wounds\u201d in clinical studies","volume":"98","author":"Kyaw BM","year":"2018","unstructured":"Kyaw BM, J\u00e4rbrink K, Martinengo L, Car J, Harding K, Schmidtchen A. Need for improved definition of \u201cchronic wounds\u201d in clinical studies. Acta Derm Venereol. 2018, 98:157-8. 10.2340\/00015555-2786","journal-title":"Acta Derm Venereol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-006-9268-7","article-title":"Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress","volume":"32","author":"Siddiq A","year":"2007","unstructured":"Siddiq A, Aminova LR, Ratan RR. Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochem Res. 2007, 32:931-46. 10.1007\/s11064-006-9268-7","journal-title":"Neurochem Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12471.x","article-title":"Iron and 8-isoprostane levels in acute and chronic wounds","volume":"121","author":"Yeoh-Ellerton S","year":"2003","unstructured":"Yeoh-Ellerton S, Stacey MC. Iron and 8-isoprostane levels in acute and chronic wounds. J Invest Dermatol. 2003, 121:918-25. 10.1046\/j.1523-1747.2003.12471.x","journal-title":"J Invest Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1177\/014107680609901122","article-title":"The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis","volume":"99","author":"Zamboni P","year":"2006","unstructured":"Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006, 99:589-93. 10.1177\/014107680609901122","journal-title":"J R Soc Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/1534734610384653","article-title":"Interplay of iron metallobiology, metalloproteinases, and FXIII, and role of their gene variants in venous leg ulcer","volume":"9","author":"Singh AV","year":"2010","unstructured":"Singh AV, Subhashree L, Milani P, Gemmati D, Zamboni P. Interplay of iron metallobiology, metalloproteinases, and FXIII, and role of their gene variants in venous leg ulcer. Int J Low Extrem Wounds. 2010, 9:166-79. 10.1177\/1534734610384653","journal-title":"Int J Low Extrem Wounds"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2010.08.015","article-title":"Skin iron deposition characterises lipodermatosclerosis and leg ulcer","volume":"40","author":"Caggiati A","year":"2010","unstructured":"Caggiati A, Rosi C, Casini A, Cirenza M, Petrozza V, Acconcia MC, Zamboni P. Skin iron deposition characterises lipodermatosclerosis and leg ulcer. Eur J Vasc Endovasc Surg. 2010, 40:777-82. 10.1016\/j.ejvs.2010.08.015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1988.01670090032006","article-title":"Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease","volume":"124","author":"Ackerman Z","year":"1988","unstructured":"Ackerman Z, Seidenbaum M, Loewenthal E, Rubinow A. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol. 1988, 124:1376-8. 10.1001\/archderm.1988.01670090032006","journal-title":"Arch Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44490","article-title":"An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice","volume":"121","author":"Sindrilaru A","year":"2011","unstructured":"Sindrilaru A, Peters T, Wieschalka S, et al.. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 2011, 121:985-97. 10.1172\/JCI44490","journal-title":"J Clin Invest"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/1754-9493-5-1","article-title":"The influence of iron status and genetic polymorphisms in the HFE gene on the risk for postoperative complications after bariatric surgery: a prospective cohort study in 1,064 patients","volume":"5","author":"Gerhard GS","year":"2011","unstructured":"Gerhard GS, Chokshi R, Still CD, et al.. The influence of iron status and genetic polymorphisms in the HFE gene on the risk for postoperative complications after bariatric surgery: a prospective cohort study in 1,064 patients. Patient Saf Surg. 2011, 5:1. 10.1186\/1754-9493-5-1","journal-title":"Patient Saf Surg"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2018.0918","article-title":"Leg ulcers in sickle-cell disease: treatment update","volume":"9","author":"Monfort JB","year":"2020","unstructured":"Monfort JB, Senet P. Leg ulcers in sickle-cell disease: treatment update. Adv Wound Care (New Rochelle). 2020, 9:348-56. 10.1089\/wound.2018.0918","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"ref54","article-title":"Diabetic Foot Ulcer","author":"Oliver TI","year":"2023","unstructured":"Oliver TI, Mutluoglu M. Diabetic Foot Ulcer. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1413445112","article-title":"Transdermal deferoxamine prevents pressure-induced diabetic ulcers","volume":"112","author":"Duscher D","year":"2015","unstructured":"Duscher D, Neofytou E, Wong VW, et al.. Transdermal deferoxamine prevents pressure-induced diabetic ulcers. Proc Natl Acad Sci U S A. 2015, 112:94-9. 10.1073\/pnas.1413445112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.04.012","article-title":"Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1\u03b1","volume":"101","author":"Hou Z","year":"2013","unstructured":"Hou Z, Nie C, Si Z, Ma Y. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1\u03b1. Diabetes Res Clin Pract. 2013, 101:62-71. 10.1016\/j.diabres.2013.04.012","journal-title":"Diabetes Res Clin Pract"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12667","article-title":"Deferoxamine can prevent pressure ulcers and accelerate healing in aged mice","volume":"26","author":"Bonham CA","year":"2018","unstructured":"Bonham CA, Rodrigues M, Galvez M, et al.. Deferoxamine can prevent pressure ulcers and accelerate healing in aged mice. Wound Repair Regen. 2018, 26:300-5. 10.1111\/wrr.12667","journal-title":"Wound Repair Regen"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2006.07.010","article-title":"Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1\/2 clinical study","volume":"193","author":"Lyons TE","year":"2007","unstructured":"Lyons TE, Miller MS, Serena T, et al.. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1\/2 clinical study. Am J Surg. 2007, 193:49-54. 10.1016\/j.amjsurg.2006.07.010","journal-title":"Am J Surg"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1139\/o11-054","article-title":"Roles of lactoferrin on skin wound healing","volume":"90","author":"Takayama Y","year":"2012","unstructured":"Takayama Y, Aoki R. Roles of lactoferrin on skin wound healing. Biochem Cell Biol. 2012, 90:497-503. 10.1139\/o11-054","journal-title":"Biochem Cell Biol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.2174\/138161207780363095","article-title":"Antibiotic properties and applications of lactoferrin","volume":"13","author":"Weinberg ED","year":"2007","unstructured":"Weinberg ED. Antibiotic properties and applications of lactoferrin. Curr Pharm Des. 2007, 13:801-11. 10.2174\/138161207780363095","journal-title":"Curr Pharm Des"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2018.0789","article-title":"Iron chelation with transdermal deferoxamine accelerates healing of murine sickle cell ulcers","volume":"7","author":"Rodrigues M","year":"2018","unstructured":"Rodrigues M, Bonham CA, Minniti CP, Gupta K, Longaker MT, Gurtner GC. Iron chelation with transdermal deferoxamine accelerates healing of murine sickle cell ulcers. Adv Wound Care (New Rochelle). 2018, 7:323-32. 10.1089\/wound.2018.0789","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14956","article-title":"Deferoxamine: potential novel topical therapeutic for chronic wounds","volume":"176","author":"Tchanque-Fossuo CN","year":"2017","unstructured":"Tchanque-Fossuo CN, Dahle SE, Buchman SR, Isseroff RR. Deferoxamine: potential novel topical therapeutic for chronic wounds. Br J Dermatol. 2017, 176:1056-9. 10.1111\/bjd.14956","journal-title":"Br J Dermatol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03479-4","article-title":"Transdermal deferoxamine administration improves excisional wound healing in chronically irradiated murine skin","volume":"20","author":"Lintel H","year":"2022","unstructured":"Lintel H, Abbas DB, Lavin CV, et al.. Transdermal deferoxamine administration improves excisional wound healing in chronically irradiated murine skin. J Transl Med. 2022, 20:274. 10.1186\/s12967-022-03479-4","journal-title":"J Transl Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.12.013","article-title":"Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition","volume":"180","author":"Han G","year":"2012","unstructured":"Han G, Nguyen LN, Macherla C, Chi Y, Friedman JM, Nosanchuk JD, Martinez LR. Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition. Am J Pathol. 2012, 180:1465-73. 10.1016\/j.ajpath.2011.12.013","journal-title":"Am J Pathol"},{"key":"ref65","article-title":"Sunscreens and Photoprotection","author":"Gabros S","year":"2023","unstructured":"Gabros S, Nessel TA, Zito PM. Sunscreens and Photoprotection. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-1974-6","article-title":"Radiation-induced fibrosis: mechanisms and implications for therapy","volume":"141","author":"Straub JM","year":"2015","unstructured":"Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015, 141:1985-94. 10.1007\/s00432-015-1974-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.12.009","article-title":"Skin wound healing in humans and mice: challenges in translational research","volume":"90","author":"Zomer HD","year":"2018","unstructured":"Zomer HD, Trentin AG. Skin wound healing in humans and mice: challenges in translational research. J Dermatol Sci. 2018, 90:3-12. 10.1016\/j.jdermsci.2017.12.009","journal-title":"J Dermatol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185358-topical-iron-chelator-therapy-current-status-and-future-prospects","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:41Z","timestamp":1707509261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185358-topical-iron-chelator-therapy-current-status-and-future-prospects"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":67,"URL":"https:\/\/doi.org\/10.7759\/cureus.47720","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}